We studied the radiosensitivity of granulocyte macrophage colony-forming units (GM-CFU) in patients with a severe combined immunodeficiency (SCID). Three patients lacking both mature T and B cells showed a twofold higher GM-CFU radiosensitivity calculated as the DO value (dose required to reduce survival to 37%), and an identical observation was made with fibroblasts from one of these patients. A patient with an SCID with hypereosinophilia, i.e., Omenn's syndrome characterized by extremely restricted T cell heterogeneity and a lack of B cells, also showed abnormal GM-CFU radiosensitivity. In contrast, GM-CFU from a patient lacking only T cells (X-linked form of SCID) showed normal GM-CFU radiosensitivity. These data further support the similarity between human T( -) B(-) SCID and the murine scid mutation characterized by a defect in T cell receptor and immunoglobulin gene rearrangement, and by an abnormal double-strand DNA break repair function. In addition, they strongly suggest that the Omeun's immunodeficiency syndrome may be a leaky T( -) B( -) SCID phenotype as previously indicated by the coexistence of the two phenotypes in siblings. (J. Clin. Invest. 1993Invest. . 91:1214Invest. -1218 
Introduction
The murine severe combined immunodeficiency (SCID)' mutation leads to faulty T and B cell differentiation because of impaired coding joint formation during both immunoglobulin and T cell receptor V(D)J gene rearrangements (1) (2) (3) . The gene involved has been assigned to chromosome 16 (4) but not characterized. The higher radiosensitivity of granulocyte macrophage colony-forming units (GM-CFU) and fibroblasts of scid mice appears result from defective double-strand DNA break repair after irradiation (5) (6) (7) . An equivalent immunological phenotype of adenosine deaminase( + )SCID in humans is characterized by the absence of mature T and B lymphocytes, while natural killer cells are present (8) . This disease shows autosomal recessive inheritance. Recently, Schwarz et al. (9) provided evidence for an abnormal recombination pattern of DH to JH elements in pre-B cells from such patients, leading to the suggestion that the human disease may resemble the murine form.
We analyzed the radiosensitivity ofmarrow GM-CFU from three patients with the T(-) B(-) SCID phenotype, healthy controls, and a patient with another type of SCID: X-linked T(-) B(+) ( 10) . We also tested GM-CFU from a patient with the Omenn immunodeficiency syndrome, a condition that could correspond to a leaky scid phenotype ( 11 ) as in scid mice (12) . GM-CFU from T(-) B(-) patients and patient with Omenn's showed increased radiosensitivity, comparable to that ofmurine scid GM-CFU, while GM-CFU from the patient with the X-linked T( -) B( +) SCID phenotype showed normal radiosensitivity. Skin fibroblasts from one T(-) B(-) SCID patient also exhibited increased radiosensitivity.
Methods
Patients. SCID was diagnosed according to the World Health Organization definition (8) . An absence of antigen-specific, cell-mediated (in vitro T cell proliferation and skin tests), and humoral immune responses was the main common feature ofthe five patients studied (Table I). Adenosine deaminase and purine nucleoside phosphorylase activities were normal, as was major histocompatibility complex class I and class II antigen expression. Lymphocyte subsets were characterized by using immunofluorescence techniques (13) (Fig. 1, A and B, arrows).
Maternal T cell engraftment was proven by caryotyping in patient 4. No maternal T cells were found by HLA typing in patients 2, 3, and 5. To test the possible X-linked inheritance ofthe B+ SCID in patient 4, X-chromosome inactivation was studied in leukocytes from the mother since there was no family history of SCID. X-chromosome inactivation analysis was performed by methylation-sensitive enzymatic digestion ofDNA isolated from PMN, T lymphocytes, or pooled EBV-derived maternal B cell lines using the M27,B (16) probe as previously described ( 17) . Both T and B lymphocytes but not PMN from the mother exhibited a skewed pattern of X-chromosome inactivation (data not shown) typical of obligate XL-SCID carriers ( 18) .
Marrow cell isolation. Mononuclear cells from the patients and healthy marrow donors were isolated by density gradient centrifugation over Ficoll-Hypaque (d = 1.077; Pharmacia, Uppsala, Sweden). Since the marrow of patient 5 was infiltrated by T cells, the latter were depleted by rosetting with 2-aminoethylisothiouronium bromidetreated red cells. A control marrow sample was similarly treated. Informed consent was obtained from all the patients' parents. Origin of patients 1 and 2 bone marrow cells was controlled by variable number tandem repeat amplification analysis indicating host origin.
Skin fibroblast cell strains and culture conditions. Two skin fibroblast cell lines were used. The human skin fibroblast cell line lBR/3 supplied by Dr. C. Arlett (University of Sussex, United Kingdom) and a skin fibroblast cell line derived from a T(-) B(-) SCID patient (patient 2 in Table I ) (19, 20) . The cells were routinely cultured in MEM (Gibco Laboratories, Grand Island, NY) supplemented with glutamine (2 mM), gentamycin (40 gsg/ml), and 15% fetal calf serum (Gibco Laboratories). Cultures were maintained in humidified 7% CO2 atmosphere at 37°C. In all experiments, the cells used were in exponential growth phase.
Irradiation. Marrow mononuclear cells were suspended in RPMI 1640 (Gibco Laboratories) at a density of 1 x 106/ml in polypropylene tubes (Falcon Labware, Oxnard, CA). Irradiation was delivered at 1 Gy/min by a "'Cs irradiator for various times. Skin fibroblast cell lines in exponential growth phase were irradiated by a "'Cs irradiator at dose rate 0.45 Gy/min.
Granulocyte macrophage progenitor cell colony assay (GM-CFU). Human GM-CFU were assayed as previously described (21 ) . Briefly, Statistical analysis. To estimate changes in GM-CFU radiation sensitivity in marrow samples of each patient as compared to controls a linear model was used (log scale). Thereafter the slopes of the linear models (patient versus controls) were compared using the Student's t test. The same method was used to compare fibroblast radiation sensitivity of patient 2 to normal controls.
Results and Discussion
As shown in Fig. 2 , GM-CFU in marrow samples from three T(-) B(-) SCID patients exhibited a clear increase in radiosensitivity (P < 0.001 ), corresponding to a twofold decrease in DO values (Table II) . It was not possible to repeat these experiments because patients' marrow samples could obviously not be obtained repeatedly. It is, however, noteworthy that the three samples showed the same increase GM-CFU radiosensitivity as in the case of GM-CFU and fibroblasts from scid mice (5) . In addition, the skin fibroblast of SCID patient 2 was also studied (Fig. 3) and showed an increased radiosensitivity (P (19) . These data strongly suggest that the human T(-) B(-) SCID phenotype may also correspond to a defect in double-strand DNA break repair (7) leading to impaired recombinase activity in T and B cells (5) . Indeed, Schwartz et al. (9) Fig. 3 ). The latter finding also showed that abnormal GM-CFU radiosensitivity did not result from the absence of marrow T cells. The SCID mutation in the mouse is often accompanied by a variable degree ofleakiness, defined by the presence ofa small number of T and/or B cell clones (3). We have previously proposed that the so-called Omenn's syndrome, which is characterized by skin and gut T cell infiltration and a profound immunodeficiency ( 1), could be a "leaky" phenotype of the human T(-) B(-) SCID ( 12) . This was based (a) on the very for GM-CFU bone marrow was exposed to various doses of y-radiation from a '37Cs irradiator. The cells were cultured as described in the text. DO is the radiation dose required to reduce the surviving fraction of cells to 0.37 in the exponential portion of the survival curve; n, the extrapolation number, is the surviving fraction obtained when the linear portion of the curve is extrapolated to zero dose and the intersection with the log survival axis is read as n.
restricted heterogeneity of T cell receptor af3 and/or ya usage in four cases studied and (b) on a case of concomitant T( -) B(-) SCID and Omenn's syndrome in two siblings. This hypothesis is supported by the present observation that the radiosensitivity of GM-CFU from a patient with a typical Omenn's syndrome (and TCR-restricted heterogeneity) ( (4) . It will be interesting to assess whether the human T(-) B(-) SCID locus maps to the syntenic region.
In conclusion, there are now three elements indicating that the human T(-) B(-) SCID phenotype is closely related to the mouse scid mutation, i.e., abnormal DH to JH rearrangement (9) , increased GM-CFU, and possibly fibroblast radiosensitivity and leakiness ( 1 1, 12 ). The parallel finding in murine and human SCID of abnormal antigen receptor recombination and increased radiosensitivity strongly suggests that both defects are the consequence of a single mutation affecting a gene encoding a molecule implicated in DNA repair. Since the number of tested patients is limited, it is still possible that there might be distinct subsets of T( -) B( -) SCID.
